<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://hipa.ai/drug/lurbinectedin/updates/trial-results-posted-nct05229588-2026-09-11</loc>
    <news:news>
      <news:publication>
        <news:name>Hipa.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-11T00:00:00.000Z</news:publication_date>
      <news:title>Lurbinectedin trial reports no responses in advanced GI cancers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04820179-2026-09-11</loc>
    <news:news>
      <news:publication>
        <news:name>Hipa.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-11T00:00:00.000Z</news:publication_date>
      <news:title>Atezolizumab trial posts pancreatic cancer activity data</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04796194-2026-09-10</loc>
    <news:news>
      <news:publication>
        <news:name>Hipa.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-10T00:00:00.000Z</news:publication_date>
      <news:title>Pembrolizumab Melanoma Trial Results Post With Response Data</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://hipa.ai/drug/adalimumab/updates/trial-results-posted-nct05640245-2026-09-10</loc>
    <news:news>
      <news:publication>
        <news:name>Hipa.ai</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-10T00:00:00.000Z</news:publication_date>
      <news:title>Adalimumab Trial Results Show Sonelokimab ACR50 Responses</news:title>
    </news:news>
  </url>
</urlset>